On April 15, 2025, MetaVia Inc. announced positive results from its Phase 1 clinical trial of DA-1726 for obesity treatment and posted an updated corporate presentation on its website.
AI Assistant
METAVIA INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.